The effect of selective phosphodiesterase inhibitors on plasma insulin concentrations and insulin secretion in vitro in the rat.
暂无分享,去创建一个
[1] D. Ward,et al. Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family. , 1996, Genomics.
[2] D. Hargrove,et al. Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo. , 1996, Metabolism: clinical and experimental.
[3] K. Brayman,et al. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion. , 1995, Biochemical and biophysical research communications.
[4] P. Arner,et al. Role of Phosphodiesterase III in the Antilipolytic Effect of Insulin in Vivo , 1995, Diabetes.
[5] J. Leblanc,et al. Metabolic and hormone-related responses to caffeine in rats. , 1995, Pharmacological research.
[6] B. Furman,et al. Effects of type‐selective phosphodiesterase inhibitors on glucose‐induced insulin secretion and islet phosphodiesterase activity , 1995, British journal of pharmacology.
[7] E. Degerman,et al. Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). , 1995, Cellular signalling.
[8] M. D. Leibowitz,et al. A Novel Insulin Secretagogue Is a Phosphodiesterase Inhibitor , 1995, Diabetes.
[9] J. Beavo,et al. Multiple cyclic nucleotide phosphodiesterases. , 1994, Molecular pharmacology.
[10] S. Kahn,et al. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. , 1994, The Journal of clinical investigation.
[11] M. Shahid,et al. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors , 1991, British journal of pharmacology.
[12] H. Rasmussen,et al. Control of insulin secretion: a model involving Ca2+, cAMP and diacylglycerol , 1990, Molecular and Cellular Endocrinology.
[13] R. Torella,et al. Theophylline prevents the inhibitory effect of prostaglandin E2 on glucose-induced insulin secretion in man. , 1988, Acta endocrinologica.
[14] B. Furman,et al. Augmentation of glucose induced insulin secretion by pertussis vaccine, phentolamine and benextramine: involvement of mechanisms additional to prevention of the inhibitory actions of catecholamines in rats. , 1988, Acta endocrinologica.
[15] B. Furman,et al. Inhibition of Glucose‐induced Insulin Secretion by Calcium Channel Blocking Drugs In‐vitro but not In‐vivo in the Rat , 1988, The Journal of pharmacy and pharmacology.
[16] D. Drucker,et al. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Houslay,et al. The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. , 1987, The Biochemical journal.
[18] H. Meissner,et al. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. , 1984, Endocrinology.
[19] H. Meissner,et al. Effects of theophylline and dibutyryl cyclic adenosine monophosphate on the membrane potential of mouse pancreatic beta‐cells. , 1984, The Journal of physiology.
[20] M. Houslay,et al. Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. , 1983, The Biochemical journal.
[21] J. Halter,et al. Effect of Intravenous Aminophylline on Plasma Levels of Catecholamines and Related Cardiovascular and Metabolic Responses in Man , 1983, Circulation.
[22] Thompson Wj,et al. Multiple cyclic nucleotide phosphodiesterase activities from rat brain , 1971 .
[23] P. Lacy,et al. Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas , 1967, Diabetes.